Dr. Gregory Lam, M.D

NPI: 1255319760
Total Payments
$392,860
2024 Payments
$46,057
Companies
15
Transactions
500
Medicare Patients
6,639
Medicare Billing
$298,090

Payment Breakdown by Category

Other$360,645 (91.8%)
Travel$18,624 (4.7%)
Food & Beverage$7,470 (1.9%)
Consulting$6,024 (1.5%)
Education$96.81 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $360,645 241 91.8%
Travel and Lodging $18,624 82 4.7%
Food and Beverage $7,470 170 1.9%
Consulting Fee $6,024 4 1.5%
Education $96.81 3 0.0%

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim Pharmaceuticals, Inc. $234,404 230 $0 (2024)
Lilly USA, LLC $145,609 208 $0 (2024)
AstraZeneca Pharmaceuticals LP $11,546 11 $0 (2019)
Novo Nordisk Inc $322.57 11 $0 (2024)
Novartis Pharmaceuticals Corporation $271.12 16 $0 (2024)
CapsoPro Services LLC $200.00 1 $0 (2020)
Boston Scientific Corporation $133.12 4 $0 (2020)
Takeda Pharmaceuticals U.S.A., Inc. $100.16 3 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $65.59 4 $0 (2023)
PFIZER INC. $59.86 3 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $46,057 53 Boehringer Ingelheim Pharmaceuticals, Inc. ($39,252)
2023 $55,939 66 Boehringer Ingelheim Pharmaceuticals, Inc. ($43,285)
2022 $70,789 74 Boehringer Ingelheim Pharmaceuticals, Inc. ($57,508)
2021 $67,917 79 Lilly USA, LLC ($38,285)
2020 $68,181 81 Lilly USA, LLC ($36,305)
2019 $82,739 137 Lilly USA, LLC ($39,009)
2018 $1,146 5 AstraZeneca Pharmaceuticals LP ($1,074)
2017 $92.70 5 Novartis Pharmaceuticals Corporation ($39.72)

All Payment Transactions

500 individual payment records from CMS Open Payments — Page 1 of 20

Date Company Product Nature Form Amount Type
12/20/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,850.00 General
Category: DIABETES
12/20/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: DIABETES
12/13/2024 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $25.77 General
Category: CARDIOVASCULAR
12/05/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Travel and Lodging In-kind items and services $56.28 General
Category: DIABETES
12/05/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Travel and Lodging In-kind items and services $27.74 General
Category: DIABETES
12/05/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $14.99 General
Category: DIABETES
11/25/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,075.00 General
Category: DIABETES
11/25/2024 Lilly USA, LLC JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: Diabetes
11/14/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $117.66 General
Category: DIABETES
11/08/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,850.00 General
Category: DIABETES
10/16/2024 Lilly USA, LLC JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: Diabetes
10/02/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $13.63 General
Category: DIABETES
09/17/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $19.30 General
Category: Cardiology/Vascular Diseases
09/09/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $20.06 General
Category: INTERNAL MEDICINE
08/21/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,375.00 General
Category: DIABETES
08/07/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Travel and Lodging In-kind items and services $104.52 General
Category: DIABETES
07/25/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $32.45 General
Category: DIABETES
07/19/2024 Esperion Therapeutics, Inc. NEXLETOL (Drug) Food and Beverage In-kind items and services $13.17 General
Category: ANTILIPEMIC AGENTS
07/17/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $28.46 General
Category: Cardiology/Vascular Diseases
07/11/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,850.00 General
Category: DIABETES
07/10/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: DIABETES
06/28/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Travel and Lodging In-kind items and services $39.93 General
Category: DIABETES
06/26/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,850.00 General
Category: DIABETES
06/26/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: DIABETES
06/21/2024 Lilly USA, LLC JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,080.00 General
Category: Diabetes

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 20 1,692 1,880 $212,940 $79,480
2022 18 1,737 1,977 $202,612 $74,783
2021 25 1,732 1,886 $199,884 $83,844
2020 20 1,478 1,620 $159,949 $59,982
Total Patients
6,639
Total Services
7,363
Medicare Billing
$298,090
Procedure Codes
84

All Medicare Procedures & Services

84 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 321 375 $70,125 $31,248 44.6%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Facility 2023 232 234 $34,632 $11,317 32.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 76 76 $22,116 $8,392 37.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 56 61 $21,899 $8,011 36.6%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 35 36 $8,820 $3,637 41.2%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 321 374 $16,082 $3,585 22.3%
78452 Nuclear medicine studies of heart muscle at rest and with stress and spect Facility 2023 51 51 $7,905 $2,838 35.9%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 21 25 $4,575 $1,557 34.0%
93016 Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician Facility 2023 110 110 $5,060 $1,545 30.5%
92960 External shock to heart to regulate heart beat Facility 2023 18 19 $4,864 $1,518 31.2%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 196 245 $4,410 $1,458 33.1%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 11 15 $3,210 $1,250 38.9%
93280 Programming of dual lead pacemaker system Office 2023 34 37 $3,120 $1,051 33.7%
93308 Ultrasound of heart, follow-up Facility 2023 33 34 $1,700 $602.33 35.4%
93018 Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician Facility 2023 53 53 $1,590 $545.06 34.3%
93288 Evaluation of single, dual, multiple lead or leadless pacemaker system Office 2023 17 24 $1,056 $366.39 34.7%
93321 Ultrasound of heart blood flow, valves and chambers, follow-up Facility 2023 36 38 $608.00 $196.35 32.3%
93320 Ultrasound of heart blood flow, valves and chambers Facility 2023 12 12 $456.00 $152.24 33.4%
93356 Heart muscle strain imaging Facility 2023 14 14 $336.00 $110.28 32.8%
93325 Ultrasound of heart with color-depicted blood flow, rate and valve function Facility 2023 45 47 $376.00 $102.77 27.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 326 387 $72,369 $31,310 43.3%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Facility 2022 257 261 $38,628 $12,248 31.7%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 56 58 $20,822 $8,595 41.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 68 68 $19,788 $7,684 38.8%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 367 462 $19,866 $4,369 22.0%

About Dr. Gregory Lam, M.D

Dr. Gregory Lam, M.D is a Internal Medicine healthcare provider based in Circleville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255319760.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Lam, M.D has received a total of $392,860 in payments from pharmaceutical and medical device companies, with $46,057 received in 2024. These payments were reported across 500 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($360,645).

As a Medicare-enrolled provider, Lam has provided services to 6,639 Medicare beneficiaries, totaling 7,363 services with total Medicare billing of $298,090. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Cardiovascular Disease
  • Location Circleville, OH
  • Active Since 01/04/2006
  • Last Updated 01/05/2022
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1255319760

Products in Payments

  • JARDIANCE (Drug) $376,278
  • FARXIGA (Drug) $1,074
  • ENTRESTO (Drug) $190.10
  • Wegovy (Drug) $177.47
  • GATTEX (Drug) $112.54
  • LEQVIO (Drug) $81.02
  • EXALT BX 4 (Device) $72.50
  • XIFAXAN (Drug) $65.59
  • VYNDAQEL (Drug) $59.86
  • Ozempic (Drug) $48.27
  • Repatha (Biological) $36.21
  • Ranexa (Drug) $27.10
  • ELIQUIS (Drug) $25.88
  • SPYGLASS (Device) $22.39
  • ACQUIRE (Device) $21.90
  • EOHILIA (Drug) $20.06
  • Rybelsus (Drug) $19.87
  • ENERGEN (Device) $16.33
  • NEXLETOL (Drug) $13.17
  • Saxenda (Drug) $12.42

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Circleville